Ipilimumab may be considered for patients with advanced melanoma, particularly those who have not responded to other treatments. It is also an option for patients with other types of cancers where clinical trials have shown benefit. As with any cancer treatment, the decision to use ipilimumab should be made in consultation with an oncologist who can consider the patient's specific condition, overall health, and treatment goals.
